Analytical Data
-
Gene name
CG-3
- Application
-
Alternative Names
CG-3；ApolipoProtein L3
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0DO16
-
Expression Region
194-605aa
-
AA Sequence
NPFLFGSNRFETLFKNQYGRIRVLQRFNQRSPQLQNLRDYRILEFNSKPNTLLLPNHADADYLIVILNGTAILSLVNNDDRDSYRLQSGDALRVPSGTTYYVVNPDNNENLRLITLAIPVNKPGRFESFFLSSTEAQQSYLQGFSRNILEASYDTKFEEINKVLFSREEGQQQGEQRLQESVIVEISKEQIRALSKRAKSSSRKTISSEDKPFNLRSRDPIYSNKLGKFFEITPEKNPQLRDLDIFLSIVDMNEGALLLPHFNSKAIVILVINEGDANIELVGLKEQQQEQQQEEQPLEVRKYRAELSEQDIFVIPAGYPVVVNATSNLNFFAIGINAENNQRNFLAGSQDNVISQIPSQVQELAFPGSAQAVEKLLKNQRESYFVDAQPKKKEEGNKGRKGPLSSILRAFY
-
Molecular Weight
54.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The CG-3 recombinant protein has garnered significant attention in the field of biotechnology and molecular biology due to its potential applications in therapeutics and diagnostics. Derived from the genome of a specific organism, CG-3 is involved in critical biological processes, including immune response modulation and cell signaling. Initial studies indicated that this protein exhibits unique structural and functional properties that could be harnessed for vaccine development, particularly in combating infectious diseases. Moreover, CG-3's interaction with various cellular pathways has led researchers to explore its role in cancer biology, where it may serve as a biomarker or therapeutic target. The recombinant production of CG-3 allows for large-scale synthesis, enabling detailed studies of its biochemical characteristics and biological activities. Furthermore, advancements in recombinant DNA technology have facilitated the engineering of CG-3 variants to enhance its efficacy and stability. As a result, the ongoing research focusing on CG-3 not only aims to elucidate its mechanisms of action but also seeks to translate these findings into practical applications that could improve public health outcomes. This research underscores the importance of understanding protein dynamics and interactions in developing innovative therapeutic strategies.
